Acquisition Opportunity OpenTempo was acquired by QGenda in 2019, indicating a market consolidation trend in physician scheduling and potential opportunities to engage customers who may be evaluating or renewing during post‑acquisition integrations.

Small Scale Growth Current revenue is under one million with a team size under 200, suggesting a SMB focus. This presents a clear path for scalable, affordable scheduling and analytics solutions that align with growth while preserving cost efficiency.

Clinical Efficiency Focus Position OpenTempo as a tool to further reduce administrative burden, optimize labor costs, and improve clinician satisfaction, which are attractive ROI points for health systems and multi‑site clinics expanding scheduling needs.

Partnership Footprint Past integrations and partnerships with TigerConnect and a history of collaboration imply openness to ecosystem integrations. Propose bundled solutions with communications and CC&C platforms to enhance value and stickiness.

Market Positioning With competitors ranging from mid‑sized to large players, emphasize differentiated analytics capabilities and rule‑based scheduling to win customers seeking cost savings and compliance, targeting similar firms in the healthcare operations space.